Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

PARNF

Parnell Pharmaceuticals (CE) (PARNF)

Parnell Pharmaceuticals Holdings Ltd (CE)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:PARNF
DateTimeSourceHeadlineSymbolCompany
08/08/201705:41Edgar (US Regulatory)Confidential Treatment Order (ct Order)USOTC:PARNFParnell Pharmaceuticals Holdings Ltd (CE)
04/08/201702:15Edgar (US Regulatory)Amended Report of Foreign Issuer (6-k/a)USOTC:PARNFParnell Pharmaceuticals Holdings Ltd (CE)
01/04/201700:36Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)USOTC:PARNFParnell Pharmaceuticals Holdings Ltd (CE)
22/03/201707:18Edgar (US Regulatory)Report of Foreign Issuer (6-k)USOTC:PARNFParnell Pharmaceuticals Holdings Ltd (CE)
15/02/201703:47Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:PARNFParnell Pharmaceuticals Holdings Ltd (CE)
04/01/201704:09Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)USOTC:PARNFParnell Pharmaceuticals Holdings Ltd (CE)
03/01/201722:01Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:PARNFParnell Pharmaceuticals Holdings Ltd (CE)
03/01/201722:01Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:PARNFParnell Pharmaceuticals Holdings Ltd (CE)
22/12/201606:51Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)USOTC:PARNFParnell Pharmaceuticals Holdings Ltd (CE)
22/12/201606:46Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)USOTC:PARNFParnell Pharmaceuticals Holdings Ltd (CE)
22/12/201606:40Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)USOTC:PARNFParnell Pharmaceuticals Holdings Ltd (CE)
22/12/201606:37Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)USOTC:PARNFParnell Pharmaceuticals Holdings Ltd (CE)
22/12/201601:43Edgar (US Regulatory)(25)USOTC:PARNFParnell Pharmaceuticals Holdings Ltd (CE)
20/12/201608:31Edgar (US Regulatory)Report of Foreign Issuer (6-k)USOTC:PARNFParnell Pharmaceuticals Holdings Ltd (CE)
20/12/201608:30GlobeNewswire Inc.Parnell Pharmaceuticals Holdings Ltd Files Form 25, Voluntarily Delisting Its Shares From NASDAQUSOTC:PARNFParnell Pharmaceuticals Holdings Ltd (CE)
10/12/201609:01Edgar (US Regulatory)Report of Foreign Issuer (6-k)USOTC:PARNFParnell Pharmaceuticals Holdings Ltd (CE)
10/12/201609:00GlobeNewswire Inc.Parnell Pharmaceuticals Holdings Ltd Announces Intention To Move From the NASDAQ OMX Global Market and Expects To Move To the...USOTC:PARNFParnell Pharmaceuticals Holdings Ltd (CE)
01/12/201623:01Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:PARNFParnell Pharmaceuticals Holdings Ltd (CE)
30/11/201623:01Edgar (US Regulatory)Report of Foreign Issuer (6-k)USOTC:PARNFParnell Pharmaceuticals Holdings Ltd (CE)
23/11/201614:34GlobeNewswire Inc.Parnell Pharmaceuticals Holdings Ltd Announces $20 Million Secured Term Loan FacilityUSOTC:PARNFParnell Pharmaceuticals Holdings Ltd (CE)
03/11/201607:01Edgar (US Regulatory)Report of Foreign Issuer (6-k)USOTC:PARNFParnell Pharmaceuticals Holdings Ltd (CE)
03/11/201607:00GlobeNewswire Inc.Parnell Pharmaceuticals Holdings Ltd Announces Financial Results for the Nine-Month Period Ended September 30, 2016USOTC:PARNFParnell Pharmaceuticals Holdings Ltd (CE)
28/10/201606:49GlobeNewswire Inc.Parnell to Report Financial Results for the Nine Months Ended September 30, 2016 on November 2, 2016USOTC:PARNFParnell Pharmaceuticals Holdings Ltd (CE)
05/08/201601:37Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:PARNFParnell Pharmaceuticals Holdings Ltd (CE)
04/08/201621:01Edgar (US Regulatory)Report of Foreign Issuer (6-k)USOTC:PARNFParnell Pharmaceuticals Holdings Ltd (CE)
04/08/201621:00GlobeNewswire Inc.Parnell Pharmaceuticals Holdings Ltd Announces Financial Results for the Six-Month Period Ended June 30, 2016USOTC:PARNFParnell Pharmaceuticals Holdings Ltd (CE)
27/07/201607:00GlobeNewswire Inc.Parnell to Report Financial Results for the Six Months Ended June 30, 2016 on August 4, 2016USOTC:PARNFParnell Pharmaceuticals Holdings Ltd (CE)
01/06/201606:07Edgar (US Regulatory)Report of Foreign Issuer (6-k)USOTC:PARNFParnell Pharmaceuticals Holdings Ltd (CE)
01/06/201606:07Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:PARNFParnell Pharmaceuticals Holdings Ltd (CE)
01/06/201606:05GlobeNewswire Inc.Parnell Pharmaceuticals Holdings Ltd Announces Contract Manufacturing Agreement with MerialUSOTC:PARNFParnell Pharmaceuticals Holdings Ltd (CE)
 Showing the most relevant articles for your search:USOTC:PARNF